Recurrence-free or progression-free survival as a surrogate endpoint for overall survival in hepatobiliary-pancreatic cancers: would be associated with time change

Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):1047-1050. doi: 10.21037/hbsn-24-597. Epub 2024 Nov 21.
No abstract available

Keywords: Surrogate endpoint; hepatobiliary-pancreatic cancers; overall survival (OS).

Publication types

  • Editorial
  • Comment